Spear Holdings RSC Ltd Boosts Stake in Danaher Corporation $DHR

Spear Holdings RSC Ltd grew its stake in shares of Danaher Corporation (NYSE:DHR) by 50.6% in the second quarter, HoldingsChannel.com reports. The fund owned 409,384 shares of the conglomerate’s stock after acquiring an additional 137,484 shares during the quarter. Danaher comprises about 5.9% of Spear Holdings RSC Ltd’s investment portfolio, making the stock its 6th biggest position. Spear Holdings RSC Ltd’s holdings in Danaher were worth $80,870,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in DHR. Capital Advisors Inc. OK increased its stake in Danaher by 1.7% in the second quarter. Capital Advisors Inc. OK now owns 174,322 shares of the conglomerate’s stock valued at $34,435,000 after acquiring an additional 2,996 shares during the last quarter. Red Tortoise LLC increased its stake in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Duncan Williams Asset Management LLC lifted its position in shares of Danaher by 4.1% during the 2nd quarter. Duncan Williams Asset Management LLC now owns 2,510 shares of the conglomerate’s stock worth $496,000 after buying an additional 100 shares during the last quarter. Sendero Wealth Management LLC acquired a new stake in Danaher in the second quarter valued at about $799,000. Finally, Valeo Financial Advisors LLC grew its position in Danaher by 8.2% in the second quarter. Valeo Financial Advisors LLC now owns 12,638 shares of the conglomerate’s stock valued at $2,496,000 after acquiring an additional 963 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DHR shares. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Evercore ISI lowered their target price on Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a report on Tuesday, July 8th. Guggenheim reissued a “buy” rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company cut their target price on Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $245.91.

Danaher Trading Down 1.6%

NYSE:DHR opened at $211.65 on Tuesday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.41. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $151.55 billion, a price-to-earnings ratio of 45.03, a PEG ratio of 3.06 and a beta of 0.77. The firm has a fifty day simple moving average of $200.36 and a two-hundred day simple moving average of $197.24.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business’s revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is currently 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.